Veena Singh, Biocept's Sr VP & Sr Med Director, recently acquired 10,000 shares of the company. The buys took place at $1.10 per share, on October 19, 2016. Singh now owns 28,333 shares of the company. Singh operates out of San Diego, CA. Some additional info was provided as follows:
Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 33,334 fewer shares.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's spouse's ownership of 3,333 fewer shares.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
Registration statement under Securities Act of 1933 - Aug. 18, 2017
Bin Li just provided an update on activist position in Biocept - Aug. 17, 2017
Major owner of Biocept just declared owning 3,147,667 shares of Biocept - Aug. 17, 2017
Notice of Exempt Offering of Securities, item 06b - Aug. 14, 2017
Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - Aug. 14, 2017